Richard M Martin

Lessons from the withdrawal of rofecoxib

Peter Jüni, P. Jüni, P. Dieppe, 2004, BMJ : British Medical Journal.

Switching prescription drugs to over the counter

P. Sullivan, Richard M Martin, R. Bunney, 2005 .

Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood Measurements

M. Schulze, I. Gram, P. Vineis, 2022, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Cancer surveillance, obesity, and potential bias.

D. Evans, A. Renehan, Richard M. Martin, 2019, The Lancet. Public health.

Carotid and femoral arterial wall changes and the prevalence of clinical cardiovascular disease

A. Nicolaides, M. Griffin, D. Bond, 2009, Vascular medicine.

Arterial Ultrasound Testing to Predict Atherosclerotic Cardiovascular Events.

A. Nicolaides, M. Griffin, D. Bond, 2022, Journal of the American College of Cardiology.

Design of a pilot prospective cohort study of adverse events monitored by hospital pharmacists

R. Mann, D. E. Hands, R. Mann, 1999 .

Allergic reactions to enoxaparin and heparin: a case report and review of the literature.

Richard M Martin, A. Tiu, Jia-Min Pang, 2004, The New Zealand medical journal.

CAP: Cluster randomised trial of testing for prostate cancer

J. Sterne, C. Metcalfe, Richard M. Martin, 2014 .